According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -6,50ย โฌ. In 2022 the company made an earnings per share (EPS) of -5,41ย โฌ a decrease over its 2021 EPS that were of -3,73ย โฌ.